He National Institute of Social Services for Retirees and Pensioners (PAMI) and the pharmaceutical entities They reached this Wednesday an agreement against the clock and it was confirmed the extension of the drug provision program To over five million retirees and pensioners.
This was reported by the agency after reaching an understanding with the Argentine Pharmaceutical Confederation (COFA), the Argentine Federation of Chambers of Pharmacies (FACAF), the Association of Mutual and Union Pharmacies of the Argentine Republic (AFMSRA), the FarmaSur Mutual Association (FMS) and the Pharmaceutical Federation of the Argentine Republic (FEFARA ).
In addition to discounts of up to 80% on sale pricesas well as the exceptional route and social subsidy for all members who need it, the entity, in charge of Esteban Leguizamohighlighted maintaining full coverage of chronic and special treatmentssuch as those related to oncology, diabetes, HIV, hemophilia, cystic fibrosis and hepatitisamong others.
“At PAMI, we are working to ensure that each member receives the necessary benefits. This investment represents an economic commitment on the part of the organization, which can only be achieved through efficient medication coverage.“said the official letter.
Lettuce sells for $8,000 per kilo: why did vegetables rise so much?
The PAMI agreement is extended with the creation of a new assistance plan
For your partpharmaceutical entities also shared the news through a statement, where they highlighted the extension of the agreementvalid since 2018, until November 30, inclusive.
Regarding the technical details, they described that the same “establishes a formula for updating the PAMI Price with the objective, during the year, to achieve a substantial reduction in the gap between prices“since, since April, the same”It will be updated accompanying the inflation index plus an additional close to 4%“.
In turn, they revealed the creation of a new assistance plan, called Eventual Coveragewhich will include molecules not covered in other plans, with 40% coverage and a 10% linear bonus in pharmacies and that it will be implemented gradually, pending the construction of the vademecum that will compose it.
“With regard to the bonuses of the rest of the plans that are part of the agreement, The current contribution percentages of pharmacies will remain unchanged. In the same sense, the payment regime will be maintained as before, so that the pharmacy continues to be able to meet the PAMI Agreement without risking working capital, by charging in advance the cost of the medications dispensed,” the document added.
In closing, he highlighted that “this way” takes “peace of mind to PAMI beneficiaries and providing pharmacies about the continuity of the service of medication dispensation, as it has been provided with professional responsibility and health efficiency throughout the country”.
It should be noted that the previously current program, which meant an investment from the National Government of more than $553,631 million in 2023, ended next March 31so the closing of the negotiations occurred in the last hours of the same.
Two kilos of fish for less than $22,000: the Central Market offers for Easter
This news takes place in the midst of a significant increase in drug prices, which, although it affects the entire population in general, hits especially older adultsthe sector that has been suffering the most from the economic crisis in recent months.
“If we take the last four months it is more than 100%, something that is obviously impacting people’s consumption. In January the increases slowed slightly with 12% and 10% during February, so with inflation it is something that is being corrected, but it is still above the CPI,” said Ricardo Pesenti, president of the Argentine Pharmaceutical Confederation. (CoFA), in dialogue with PERFIL.
News in development…